Abstract
The case of a 41-year-old male patient is described who developed acute reversible hepatitis related to etretinate therapy. During the course of etretinate he received 2 doses of hepatitis B vaccine; this and his HLA typing A1, A2, Bw57, Cw6 may have predisposed him to develop this reaction.
MeSH terms
-
Acute Disease
-
Adult
-
Chemical and Drug Induced Liver Injury / etiology*
-
Chemical and Drug Induced Liver Injury / immunology
-
Etretinate / adverse effects*
-
HLA Antigens / analysis
-
Hepatitis B Vaccines
-
Humans
-
Male
-
Psoriasis / drug therapy
-
Risk Factors
-
Viral Hepatitis Vaccines / administration & dosage
-
Viral Hepatitis Vaccines / adverse effects*
Substances
-
HLA Antigens
-
Hepatitis B Vaccines
-
Viral Hepatitis Vaccines
-
Etretinate